|Bid||169.51 x 800|
|Ask||169.78 x 1000|
|Day's Range||168.95 - 171.21|
|52 Week Range||155.02 - 362.29|
|Beta (5Y Monthly)||0.37|
|PE Ratio (TTM)||31.71|
|Earnings Date||Apr 29, 2020 - May 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||216.00|
Abiomed, Inc. (NASDAQ:ABMD) last week reported its latest quarterly results, which makes it a good time for investors...
Medical stocks struggled in January. But the best performing among them include medical technology companies that tend to have high Composite Ratings, a key metric measuring growth.
NEW YORK, NY / ACCESSWIRE / February 6, 2020 / ABIOMED, Inc. (NASDAQ:ABMD) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on February 6, 2020 at 8:00 AM ...
Despite the ongoing US-China trade war, increased focus on innovation is likely to have driven performance of medical products players' quarterly performance.
Earnings are the single best guide in the stock market in the long term. Only 8% of the strong move up in the stock market last year was attributable to earnings. The rest was triggered by the Federal Reserve reversing its policy of raising interest rates, which boosted sentiment, especially among the momo (momentum) crowd.
The three major U.S. stock market indexes rose as investors looked ahead to Wednesday’s signing of the initial U.S.-China trade pact.
Abiomed (ABMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Today we'll look at Abiomed, Inc. (NASDAQ:ABMD) and reflect on its potential as an investment. To be precise, we'll...